{
    "nct_id": "NCT04232670",
    "official_title": "Pancreatic Endotherapy for Refractory Chronic Pancreatitis",
    "inclusion_criteria": "Inclusion Criteria\n\n* Age ≥ 18 years\n* Main pancreatic duct obstruction, defined by the presence of one or both of the following features:\n* Main pancreatic duct calcification with upstream main duct dilation ≥6mm.\n* Main pancreatic duct stricture, defined by the presence of main pancreatic duct narrowing with upstream main duct dilation ≥6mm.\n* Baseline average abdominal pain score ≥4 during the run-in period, based on Ecological Momentary Assessment 11-point Numeric Rating Scale\n* Ability to provide written, informed consent\n\nExclusion Criteria\n\n* Symptoms attributable to a pancreatic pseudocyst or walled off necrosis\n* Clinical suspicion of pancreatobiliary malignancy*\n* Low probability of follow-up to complete study objectives\n* Pregnancy or incarceration\n* Medical comorbidities that contraindicate the performance of ERCP\n* Previous pancreatic endotherapy\n* Current Opioid Misuse Measure score ≥9\n* Does not have access to a mobile phone * Pancreatobiliary malignancy\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}